Replies to post #790 on OWC Pharmaceutical Research Corp (OWCP)

[stockseekerok]

As of November 25, 2014, the Registrant had 73,383,195 shares of Common Stock issued and outstanding.
Name of Beneficial Owner Common Stock Beneficially Owned Percentage of Common Stock Owned
Mordechai Bignitz, CEO and Chairman 0 0.00%
7 Jacobtinsky Street, Ramat Gan 52520, Israel
Shmuel De-Saban, CFO 135,500 0.18%
215 Jaffa Street, Jerusalem, Israel
Ziv Turner, CEO of OWC 2,104,480 2.87%
Shaham 22 Street, Petach Tiqwa 49181, Israel
Dr. Alan Shackelford, CSO of OWC 5,134,375 7.00%
2257 South Broadway, Denver, CO 80210
Alon Sinai, COO of OWC 861,250 1.17%
Shaham 22 Street, Petach Tiqwa 49181, Israel
Uri Glazer, VP of OWC 2,144,480 2.88%
Shaham 22 Street, Petach Tiqwa 49181, Israel
Jacky Shenker 8,000,000 10.90%
78 Uziel Street, Jerusalem, Israel
Kfir Silberman 3,964,300 5.88%
5 Shoshanin Street, Ramat Gan, Israel
Director and Officer (6 person) (2) 10,380,085 14.15%

All Directors and Officers as a group (6 persons), including those of the Registrant's wholly-owned subsidiary, One World Cannabis Ltd own 10,376,575 shares.